Our research initially demonstrated the value of measuring the intensity of FN1 mRNA or FN1 protein expression in postoperative tumor specimens from patients with ESCC in determining the prognosis of patients. The gene discussed is FN1; the disease is esophageal squamous cell carcinoma.